Glycovaxin is a startup based in Germany, most recent round Seed, 1 tracked investor.
Glycovaxin is a company founded in 2018 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Glycovaxin is a biotechnology company developing a new generation of vaccines against bacterial infections. They utilize synthetic carbohydrate chemistry to create innovative vaccine candidates.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.